纳米技术在类风湿性关节炎治疗方法中的重大进展展望

IF 0.3 Q4 PHARMACOLOGY & PHARMACY
Amana Parveen, Pranay Wal, Awani Kumar Rai, Ankita Wal
{"title":"纳米技术在类风湿性关节炎治疗方法中的重大进展展望","authors":"Amana Parveen, Pranay Wal, Awani Kumar Rai, Ankita Wal","doi":"10.2174/0115748855238869231002073717","DOIUrl":null,"url":null,"abstract":"Background: Rheumatoid arthritis affects roughly 5 out of every 1000 persons, rheumatoid arthritis is a persistent anarchic ailment with complicated pathophysiology a well-known cause of arthritis-related stinging apropos nexus, degradation of synovium, the creation of pannus, damage to bones, and loss of the cartilage. Thus, it is imperative to diagnose and treat rheumatoid arthritis. Due to rheumatoid arthritis's complexity, early diagnosis is difficult, which makes the treatment difficult. Moreover, anti- rheumatoid arthritis drugs taken on a long-term basis can damage patients' organs as well. Due to this, these anti- rheumatoid arthritis medications may cause severe side effects in extra-articular tissues since they cannot selectively target the affected zone. There has been substantial progress in the discovery of this disease's pathophysiology and treatment strategy over the past few years, as well as in developing effective diagnostic methods, early detection, and efficient treatment strategies. In the rheumatoid arthritis, nanotechnology has come to the fore as a game-changer in effectively managing many diseases. Various nanotechnology approaches are promising for designing formulations that can deliver drugs to bone and cartilage in targeted and non-targeted ways like Targeting receptors on inflammation-related cells (CD44, Scavengers receptors, etc.) Conclusion: Nanotechnology is used to treat Rheumatoid arthritis, improve implants and prostheses, and develop new diagnostic and treatment methods in orthopedic medicine. Many chronic orthopedic diseases exist, but rheumatoid arthritis is the most common. Several research studies have found that nanotechnology could deliver targeted drugs, reduce adverse effects on non-target organs, increase drug concentration in synovial tissues, and slow the progression of immune-mediated rheumatoid diseases such as rheumatoid arthritis. This review examines how nanotechnology can be used to diagnose and treat rheumatoid arthritis.","PeriodicalId":11004,"journal":{"name":"Current Drug Therapy","volume":"49 1","pages":"0"},"PeriodicalIF":0.3000,"publicationDate":"2023-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An Outlook of Substantial Progress in Nanotechnology Emerged in Treatment Approaches for Rheumatoid Arthritis\",\"authors\":\"Amana Parveen, Pranay Wal, Awani Kumar Rai, Ankita Wal\",\"doi\":\"10.2174/0115748855238869231002073717\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Rheumatoid arthritis affects roughly 5 out of every 1000 persons, rheumatoid arthritis is a persistent anarchic ailment with complicated pathophysiology a well-known cause of arthritis-related stinging apropos nexus, degradation of synovium, the creation of pannus, damage to bones, and loss of the cartilage. Thus, it is imperative to diagnose and treat rheumatoid arthritis. Due to rheumatoid arthritis's complexity, early diagnosis is difficult, which makes the treatment difficult. Moreover, anti- rheumatoid arthritis drugs taken on a long-term basis can damage patients' organs as well. Due to this, these anti- rheumatoid arthritis medications may cause severe side effects in extra-articular tissues since they cannot selectively target the affected zone. There has been substantial progress in the discovery of this disease's pathophysiology and treatment strategy over the past few years, as well as in developing effective diagnostic methods, early detection, and efficient treatment strategies. In the rheumatoid arthritis, nanotechnology has come to the fore as a game-changer in effectively managing many diseases. Various nanotechnology approaches are promising for designing formulations that can deliver drugs to bone and cartilage in targeted and non-targeted ways like Targeting receptors on inflammation-related cells (CD44, Scavengers receptors, etc.) Conclusion: Nanotechnology is used to treat Rheumatoid arthritis, improve implants and prostheses, and develop new diagnostic and treatment methods in orthopedic medicine. Many chronic orthopedic diseases exist, but rheumatoid arthritis is the most common. Several research studies have found that nanotechnology could deliver targeted drugs, reduce adverse effects on non-target organs, increase drug concentration in synovial tissues, and slow the progression of immune-mediated rheumatoid diseases such as rheumatoid arthritis. This review examines how nanotechnology can be used to diagnose and treat rheumatoid arthritis.\",\"PeriodicalId\":11004,\"journal\":{\"name\":\"Current Drug Therapy\",\"volume\":\"49 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2023-10-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Drug Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0115748855238869231002073717\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Drug Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115748855238869231002073717","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:类风湿关节炎影响大约每1000人中有5人,类风湿关节炎是一种具有复杂病理生理的持续无规律疾病,是众所周知的关节炎相关刺痛,滑膜退化,滑膜形成,骨骼损伤和软骨丢失的原因。因此,类风湿关节炎的诊断和治疗势在必行。由于类风湿关节炎的复杂性,早期诊断是困难的,这使得治疗困难。此外,长期服用抗风湿性关节炎药物也会损害患者的器官。因此,这些抗类风湿性关节炎药物可能会在关节外组织中引起严重的副作用,因为它们不能选择性地靶向患处。在过去的几年中,在发现该病的病理生理学和治疗策略以及制定有效的诊断方法、早期发现和有效的治疗策略方面取得了实质性进展。在类风湿性关节炎中,纳米技术已经成为有效管理许多疾病的游戏规则改变者。各种纳米技术方法有望设计出能够以靶向和非靶向方式向骨和软骨输送药物的配方,如靶向炎症相关细胞上的受体(CD44,清道夫受体等)。结论:纳米技术可用于治疗类风湿性关节炎,改善植入物和假体,并在骨科医学中开发新的诊断和治疗方法。许多慢性骨科疾病存在,但类风湿关节炎是最常见的。一些研究发现,纳米技术可以递送靶向药物,减少对非靶器官的不利影响,增加滑膜组织中的药物浓度,并减缓免疫介导的类风湿疾病(如类风湿关节炎)的进展。本文综述了如何利用纳米技术诊断和治疗类风湿性关节炎。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
An Outlook of Substantial Progress in Nanotechnology Emerged in Treatment Approaches for Rheumatoid Arthritis
Background: Rheumatoid arthritis affects roughly 5 out of every 1000 persons, rheumatoid arthritis is a persistent anarchic ailment with complicated pathophysiology a well-known cause of arthritis-related stinging apropos nexus, degradation of synovium, the creation of pannus, damage to bones, and loss of the cartilage. Thus, it is imperative to diagnose and treat rheumatoid arthritis. Due to rheumatoid arthritis's complexity, early diagnosis is difficult, which makes the treatment difficult. Moreover, anti- rheumatoid arthritis drugs taken on a long-term basis can damage patients' organs as well. Due to this, these anti- rheumatoid arthritis medications may cause severe side effects in extra-articular tissues since they cannot selectively target the affected zone. There has been substantial progress in the discovery of this disease's pathophysiology and treatment strategy over the past few years, as well as in developing effective diagnostic methods, early detection, and efficient treatment strategies. In the rheumatoid arthritis, nanotechnology has come to the fore as a game-changer in effectively managing many diseases. Various nanotechnology approaches are promising for designing formulations that can deliver drugs to bone and cartilage in targeted and non-targeted ways like Targeting receptors on inflammation-related cells (CD44, Scavengers receptors, etc.) Conclusion: Nanotechnology is used to treat Rheumatoid arthritis, improve implants and prostheses, and develop new diagnostic and treatment methods in orthopedic medicine. Many chronic orthopedic diseases exist, but rheumatoid arthritis is the most common. Several research studies have found that nanotechnology could deliver targeted drugs, reduce adverse effects on non-target organs, increase drug concentration in synovial tissues, and slow the progression of immune-mediated rheumatoid diseases such as rheumatoid arthritis. This review examines how nanotechnology can be used to diagnose and treat rheumatoid arthritis.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current Drug Therapy
Current Drug Therapy PHARMACOLOGY & PHARMACY-
CiteScore
1.30
自引率
0.00%
发文量
50
期刊介绍: Current Drug Therapy publishes frontier reviews of high quality on all the latest advances in drug therapy covering: new and existing drugs, therapies and medical devices. The journal is essential reading for all researchers and clinicians involved in drug therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信